Cargando…
Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
BACKGROUND: Hypertension (HTN) is the most frequent adverse event during treatment with lenvatinib (LEN), but data on its best management are limited. AIM: The objective of this study was to assess incidence, features and best management of LEN-related HTN in a consecutive single tertiary-care centr...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308446/ https://www.ncbi.nlm.nih.gov/pubmed/37097040 http://dx.doi.org/10.1530/ETJ-23-0047 |